secwatch.observer — SEC 8-K summary
======================================

Issuer:     T2 Biosystems, Inc. (—)
CIK:        0001492674
Form:       8-K
Filed at:   2023-05-23T23:59:59+00:00
Accession:  0001193125-23-151808
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

T2 Biosystems receives Nasdaq delisting notice for market value below $35M
--------------------------------------------------------------------------

- MVLS below $35M minimum for 30 consecutive business days as of Nov 22, 2022; compliance period ended May 22, 2023.
- Nasdaq notified T2 on May 23, 2023 that shares fail to comply and are subject to delisting.
- Company will appeal and request a hearing to stay delisting pending Panel decision.
- T2 intends to present a plan to regain compliance, but no assurance of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1492674/000119312523151808/0001193125-23-151808-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1492674/000119312523151808/d447004d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-151808

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer